Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition

DOI: 10.1080/2162402X.2017.1388485

Keywords: Cancer Immunotherapy, EMT, Inflammation, Oncogene, Therapeutic Antibodies

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text